Active ingredientMefloquine HClCat. No. P-M033-001CAS 51773-92-3Family · Pharmaceutical analytical standards
Mefloquine
A quinoline antimalarial developed in the United States in the 1970s and first approved in Switzerland in 1984: it is used to prevent and treat malaria, including chloroquine-resistant malaria. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It emerged from a gigantic screening effort: it was compound number 142,490 among about 250,000 molecules tested in the search for new antimalarials.
Go to the active ingredient →Active ingredientMefloquine HClCat. No. P-M033-001CAS 51773-92-3
Pharmacopoeial impurityMefloquine EP Impurity BCat. No. P-M033-002CAS 68496-04-8
Isotopically labelledDehydro Mefloquine-d5Cat. No. P-M033-003CAS 1246819-32-8
Isotopically labelledMefloquine Impurity 1-d4Cat. No. P-M033-004
NitrosamineN-Nitroso MefloquineCat. No. P-M033-005![(RS)-[2,8-Bis(trifluoromethyl)quinolin-4-yl][(2RS)-piperidin-2-yl]methanol Hydrochloride](https://img.vitasanlabs.com/vsl-struct/P-M033-006.svg?v=41e934f030)
Impurity(RS)-[2,8-Bis(trifluoromethyl)quinolin-4-yl][(2RS)-piperidin-2-yl]methanol HydrochlorideCat. No. P-M033-006CAS 58560-52-4
Impurity2,8-Bis(trifluoromethyl)-4-quinolinolCat. No. P-M033-007CAS 35853-41-9
ImpurityCarboxymefloquineCat. No. P-M033-008CAS 35853-50-0No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceMefloquine hydrochloride CRSEDQM code M0253000Family MefloquineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.